Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Twitter summary: Using a #T2D therapy for #T1D, Lexicon & JDRF partner up for phase 2 trial of SGLT-2/SGLT-1 dual inhibitor drug On July 9, Lexicon announced a...
What can diabetes advocates learn from the HIV/AIDS movement? Part five of our exclusive interview with David Panzirer and Dana Ball.
On April 29, the FDA issued a strongly-worded safety communication that advised patients and health care providers to stop using the GenStrip from Shasta Technologies, a...
Navigating diabetes in high school – the four strategies I follow to stay safe.
Twitter summary: BD’s new pen needle attacks #needlephobia at the source – now available at US pharmacies On August 6, BD announced the US launch of the Autoshield Duo...
Twitter summary: Glooko launches MeterSync Blue, 30+ meters to send data to iPhone/Android app via Bluetooth using only 1 piece of hardware This month Glooko announced...
Could Tidepool’s software change type 1 diabetes?
On July 3, Dr. Ed Damiano addressed the Friends for Life Conference in Orlando with the latest update on his team’s bionic pancreas, which involves automated insulin+...
Twitter summary: Contrave launched in the US w/ weight support program + savings/loyalty programs offer new option for patients Two healthcare companies, Orexigen and...
Advances in type 1 diabetes at The American Diabetes Association 74th Scientific Sessions
What do you know about diabetes education? Our interview with AADE President Joan Bardsley.
Twitter Summary: The ShugaTrak app sends updates on child’s BGM to parents in real time – currently available for Android phones At this year’s Friends for Life...
Kids First, Diabetes Second – a guide to the small and big issues of raising a child with type 1 diabetes.
German pharmaceutical company Merck KGaA has launched a pilot program in Kenya and Uganda to improve the outcomes of diabetes care through a text messaging campaign...
(S)he said what?!?
Twitter summary: Exciting positive vote for #liraglutide #emdac on possible new therapy for #obesity! Plus, our favorite open public hearing yet. Yesterday on September...
On September 24, JAMA published a paper on long-term trends in the number of people with diabetes in the United States from 1980 to 2012. The results showed a leveling-...
(S)he said what?!?
On June 19, Novo Nordisk announced the launch of its FlexTouch pen for the long-acting basal insulin Levemir (insulin detemir). FlexTouch, which has been approved in...
Twitter summary: Take the #BigBlueTest to get active, spread #diabetes awareness, and raise money for non-profits helping #PWD! Want an easy and fun way to spread...

Pages